|
Determination of Lactate Dehydrogenase Serum Levels in Patients with COVID-2019 and the Factors Affecting Their Mortality in Chabahar, Iran (2021)
|
Shahabuddin Mollazaei1    , Amirabbas Minaeifar * 2, Mahboubeh Mirhosseini3 , Sadieh Dehghani Firouzabadi4 |
1- M.Sc Student of Biochemistry, School of Fundamental Sciences, Payame Noor University, Tehran, Iran.
2- Associate Professor, Department of Biology, School of Fundamental Sciences, Payame Noor University, Tehran, Iran. , aaminaeifar@pnu.ac.ir
3- Associate Professor, Department of Biology, School of Fundamental Sciences, Payame Noor University, Tehran, Iran.
4- General Physician, Department of Infectious Diseases & Tropical Medicine, School of Medicine, Shahid Sadoughi University of Medical Sciences, Yazd, Iran. |
|
|
Abstract: (1377 Views) |
Background and Objective: Coronavirus disease 2019 (COVID-19) can lead to organ failure by the occurrence of mechanisms such as increased thrombosis and, subsequently, increased lactate dehydrogenase (LDH). This study was conducted to determine LDH serum levels in COVID-19 patients and the factors affecting their mortality.
Methods: This descriptive-analytical study was conducted on 212 patients (57 males and 155 females) with COVID-19 with a mean age of 49.19±10.6 referring to Imam Ali Hospital in Chabahar, Iran during 2021. After obtaining patients’ informed consent and demographic information, the heparinized peripheral blood sample was taken from them. The LHD levels were determined using an autoanalyzer.
Results: Twenty-nine (13.67%) patients died. The mean LDH serum level of 29 deceased patients (708.420±96.25 U/L) was not statistically significant compared to survivors (640.360±96.80 U/L in 183). The comparison between the surviving and deceased groups showed that 25% of the deceased patients were hospitalized in the intensive care unit (ICU), and 90.90% of the survivors were hospitalized in the internal ward (P<0.05). All the deceased and 85.85% of the survivors were 40 years old and above, and this difference was not statistically significant. Furthermore, 24.56% of the deceased were male, 90.32% of the survivors were female (P<0.05), 22.72% of the deceased had a university education, and 88.69% of the survivors had a diploma or under-diploma education (P<0.05), and 71.42% of the deceased patients had thin, and 91.37% of the survivors were overweight (P<0.05).
Conclusion: There was no difference in the LDH serum levels of the COVID-19 survivors and deceased. The age of 40 years and above, lean and morbidly obese body mass indices, male gender, and the need for hospitalization in the ICU were determined as risk factors. |
|
Keywords: Coronavirus [MeSH], COVID-19 [MeSH], Lactate Dehydrogenase [MeSH], Mortality [MeSH]
Article ID: Vol25-47 |
|
|
Full-Text [PDF 718 kb]
(3998 Downloads)
|
|
Type of Study: Original Articles |
Subject:
Health System
|
|
|
|
|
|
|
| References |
1. Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: What we know. Int J Infect Dis. 2020 May; 94: 44-48. doi: 10.1016/j.ijid.2020.03.004. [ DOI] [ PubMed] 2. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application. Ann Intern Med. 2020 May; 172(9): 577-82. doi: 10.7326/M20-0504. [ DOI] [ PubMed] 3. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020 Feb; 395(10223): 497-506. doi: 10.1016/S0140-6736(20)30183-5. [ DOI] [ PubMed] 4. Lu J, Wei Z, Jiang H, Cheng L, Chen Q, Chen M, Yan J, Sun Z. Lactate dehydrogenase is associated with 28-day mortality in patients with sepsis: a retrospective observational study. J Surg Res. 2018 Aug; 228: 314-21. doi: 10.1016/j.jss.2018.03.035. [ DOI] [ PubMed] 5. Rifai N. Tietz textbook of clinical chemistry and molecular diagnostics. 6th ed. New York: St.Louis. 2017; p: 1888. 6. Passarella S, Schurr A. l-Lactate Transport and Metabolism in Mitochondria of Hep G2 Cells-The Cori Cycle Revisited. Front Oncol. 2018 Apr; 8: 120. doi: 10.3389/fonc.2018.00120. [ DOI] [ PubMed] 7. Mekawy MM, Hassan RYA, Ramnani P, Yu X, Mulchandani A. Electrochemical detection of dihydronicotinamide adenine dinucleotide using Al2O3-GO nanocomposite modified electrode. Arabian Journal of Chemistry. 2018 Sep; 11(6): 942-49. doi: 10.1016/j.arabjc.2018.03.017. [ Link] [ DOI] 8. Jurisic V, Radenkovic S, Konjevic G. The Actual Role of LDH as Tumor Marker, Biochemical and Clinical Aspects. Adv Exp Med Biol. 2015; 867: 115-24. doi: 10.1007/978-94-017-7215-0_8. [ DOI] [ PubMed] 9. Dzsudzsák E, Sütő R, Pócsi M, Fagyas M, Szentkereszty Z, Nagy B Jr. Profiling of Lactate Dehydrogenase Isoenzymes in COVID-19 Disease. EJIFCC. 2021 Dec; 32(4): 432-41. [ PubMed] 10. Serrano-Lorenzo P, Coya ON, López-Jimenez A, Blázquez A, Delmiro A, Lucia A, et al. Plasma LDH: A specific biomarker for lung affectation in COVID-19? Pract Lab Med. 2021 May; 25: e00226. doi: 10.1016/j.plabm.2021.e00226. [ DOI] [ PubMed] 11. Li C, Ye J, Chen Q, Hu W, Wang L, Fan Y, et al. Elevated Lactate Dehydrogenase (LDH) level as an independent risk factor for the severity and mortality of COVID-19. Aging (Albany NY). 2020 Aug; 12(15): 15670-81. doi: 10.18632/aging.103770. [ DOI] [ PubMed] 12. Martha JW, Wibowo A, Pranata R. Prognostic value of elevated lactate dehydrogenase in patients with COVID-19: a systematic review and meta-analysis. Postgrad Med J. 2022 Jun; 98(1160): 422-27. doi: 10.1136/postgradmedj-2020-139542. [ DOI] [ PubMed] 13. Zhang J, Wang X, Jia X, Li J, Hu K, Chen G, et al. Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clin Microbiol Infect. 2020 Jun; 26(6): 767-72. doi: 10.1016/j.cmi.2020.04.012. [ DOI] [ PubMed] 14. Tietz NW. Tietz Textbook of Clinical Chemistry. 2 illustrated. Philadephia: Saunders. 1994. 15. Adams A, Straseski JA, Lehman CM, Pearson LN. Peritoneal and Pleural Fluid Chemistry Measurements Performed on Three Chemistry Platforms. Lab Med. 2019 Apr; 50(2): 145-49. doi: 10.1093/labmed/lmy056. [ DOI] [ PubMed] 16. Sharma LK, Dutta D, Sharma N, Thakur B. Comparisons of metabolite profile from paired serum and ethylenediaminetetraacetic acid-plasma samples using dry chemistry technology: An emergency department perspective. J Lab Physicians. 2018 Jul-Sep; 10(3): 346-50. doi: 10.4103/JLP.JLP_151_17. [ DOI] [ PubMed] 17. Fialek B, Pruc M, Smereka J, Jas R, Rahnama-Hezavah M, Denegri A, et al. Diagnostic value of lactate dehydrogenase in COVID-19: A systematic review and meta-analysis. Cardiol J. 2022; 29(5): 751-58. doi: 10.5603/CJ.a2022.0056. [ DOI] [ PubMed] 18. Qiu P, Zhou Y, Wang F, Wang H, Zhang M, Pan X, et al. Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis. Aging Clin Exp Res. 2020 Sep; 32(9): 1869-78. doi: 10.1007/s40520-020-01664-3. [ DOI] [ PubMed] 19. Kashefizadeh A, Ohadi L, Golmohammadi M, Araghi F, Dadkhahfar S, Kiani A, et al. Clinical features and short-term outcomes of COVID-19 in Tehran, Iran: An analysis of mortality and hospital stay. Acta Biomed. 2020 Nov; 91(4): e2020147. doi: 10.23750/abm.v91i4.10206. [ DOI] [ PubMed] 20. Bwire GM. Coronavirus: Why Men are More Vulnerable to Covid-19 Than Women? SN Compr Clin Med. 2020; 2(7): 874-76. doi: 10.1007/s42399-020-00341-w. [ DOI] [ PubMed] 21. Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020 May; 11(1): 29. doi: 10.1186/s13293-020-00304-9. [ DOI] [ PubMed] 22. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020 Mar; 323(11): 1061-69. doi: 10.1001/jama.2020.1585. [ DOI] [ PubMed] 23. Grasselli G, Pesenti A, Cecconi M. Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy: Early Experience and Forecast During an Emergency Response. JAMA. 2020 Apr; 323(16): 1545-46. doi: 10.1001/jama.2020.4031. [ DOI] [ PubMed] 24. Azizmohammad Looha M, Rezaei-Tavirani M, Rostami-Nejad M, Janbazi S, Zarean E, Amini P, et al. Assessing sex differential in COVID-19 mortality rate by age and polymerase chain reaction test results: an Iranian multi-center study. Expert Rev Anti Infect Ther. 2022 Apr; 20(4): 631-41. doi: 10.1080/14787210.2022.2000860. [ DOI] [ PubMed] 25. Turcotte JJ, Meisenberg BR, MacDonald JH, Menon N, Fowler MB, West M, et al. Risk factors for severe illness in hospitalized Covid-19 patients at a regional hospital. PLoS One. 2020 Aug; 15(8): e0237558. doi: 10.1371/journal.pone.0237558. [ DOI] [ PubMed] 26. Peña JE, Rascón-Pacheco RA, Ascencio-Montiel IJ, González-Figueroa E, Fernández-Gárate JE, Medina-Gómez OS, et al. Hypertension, Diabetes and Obesity, Major Risk Factors for Death in Patients with COVID-19 in Mexico. Arch Med Res. 2021 May; 52(4): 443-49. doi: 10.1016/j.arcmed.2020.12.002. [ DOI] [ PubMed] 27. Klang E, Kassim G, Soffer S, Freeman R, Levin MA, Reich DL. Severe Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50. Obesity (Silver Spring). 2020 Sep; 28(9): 1595-99. doi: 10.1002/oby.22913. [ DOI] [ PubMed] 28. Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism. 2020 Jul; 108: 154262. doi: 10.1016/j.metabol.2020.154262. [ DOI] [ PubMed] 29. Popkin BM, Du S, Green WD, Beck MA, Algaith T, Herbst CH, et al. Individuals with obesity and COVID-19: A global perspective on the epidemiology and biological relationships. Obes Rev. 2020 Nov; 21(11): e13128. doi: 10.1111/obr.13128. [ DOI] [ PubMed] 30. Luzi L, Radaelli MG. Influenza and obesity: its odd relationship and the lessons for COVID-19 pandemic. Acta Diabetol. 2020 Jun; 57(6): 759-64. doi: 10.1007/s00592-020-01522-8. [ DOI] [ PubMed] 31. Ni YN, Luo J, Yu H, Wang YW, Hu YH, Liu D, et al. Can body mass index predict clinical outcomes for patients with acute lung injury/acute respiratory distress syndrome? A meta-analysis. Crit Care. 2017 Feb; 21(1): 36. doi: 10.1186/s13054-017-1615-3. [ DOI] [ PubMed] 32. Jose RJ, Manuel A. Does Coronavirus Disease 2019 Disprove the Obesity Paradox in Acute Respiratory Distress Syndrome? Obesity (Silver Spring). 2020 Jun; 28(6): 1007. doi: 10.1002/oby.22835. [ DOI] [ PubMed] 33. Kim SY, Yoo DM, Min C, Wee JH, Kim JH, Choi HG. Analysis of Mortality and Morbidity in COVID-19 Patients with Obesity Using Clinical Epidemiological Data from the Korean Center for Disease Control & Prevention. Int J Environ Res Public Health. 2020 Dec; 17(24): 9336. doi: 10.3390/ijerph17249336. [ DOI] [ PubMed] 34. Taylor AK, Cao W, Vora KP, De La Cruz J, Shieh WJ, Zaki SR, et al. Protein energy malnutrition decreases immunity and increases susceptibility to influenza infection in mice. J Infect Dis. 2013 Feb; 207(3): 501-10. doi: 10.1093/infdis/jis527. [ DOI] [ PubMed] |
|
| Send email to the article author |
|
|
|
Mollazaei S, Minaeifar A, Mirhosseini M, Dehghani Firouzabadi S. Determination of Lactate Dehydrogenase Serum Levels in Patients with COVID-2019 and the Factors Affecting Their Mortality in Chabahar, Iran (2021). J Gorgan Univ Med Sci 2023; 25 (4) :63-70 URL: http://goums.ac.ir/journal/article-1-4301-en.html
|
